| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.048 | 0.8 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.015 | 0.8 |